Compare Deere & Company (DE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deere & Company vs Regeneron Pharmaceuticals Inc — how do they compare? Deere & Company trades at $584.4 (market cap $158.09B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Deere & Company is far larger — about 2.3× Regeneron Pharmaceuticals Inc's market cap, and Deere & Company pays the higher dividend (1.11%). Which is the better fit depends on your goals.
| DE | REGN | |
|---|---|---|
Market Cap | $158.09B | $69.52B |
Sector | Industrials | Health |
52-Week High | $662.49 | $812.27 |
52-Week Low | $439.11 | $542.52 |
Enterprise Value | $212.91B | $63.47B |
Dividend Yield | 1.11% | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
